TRANSINE Trademark

Trademark Overview


On Thursday, February 11, 2021, a trademark application was filed for TRANSINE with the United States Patent and Trademark Office. The USPTO has given the TRANSINE trademark a serial number of 79316838. The federal status of this trademark filing is REGISTERED as of Tuesday, August 16, 2022. This trademark is owned by Transine Therapeutics Limited. The TRANSINE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DN...

Chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use

Scientific and technological services and research and design relating thereto, namely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; research, development, testing and analysis for scientific research purposes in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene editing services for scientific research purposes; DNA and RNA modelling services, namely genetic mapping for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collec...
transine

General Information


Serial Number79316838
Word MarkTRANSINE
Filing DateThursday, February 11, 2021
Status700 - REGISTERED
Status DateTuesday, August 16, 2022
Registration Number6816931
Registration DateTuesday, August 16, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DNA and RNA, namely, nucleic acid sequences for medical purposes
Goods and ServicesChemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
Goods and ServicesScientific and technological services and research and design relating thereto, namely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; research, development, testing and analysis for scientific research purposes in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene editing services for scientific research purposes; DNA and RNA modelling services, namely genetic mapping for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating and providing databases or collections of information on normal and mutated genes for scientific research purposes; scientific services relating to the discovery, preclinical and clinical development of therapeutic products, namely therapeutic DNA and RNA; consultancy and advisory services relating to the aforesaid services; research and development of synthetic DNA, RNA, genes and oligonucleotides for others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHarness Therapeutics Limited
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressGB

Party NameHarness Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameTransine Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameTransine Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, July 29, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, August 9, 2021ASSIGNED TO EXAMINER
Wednesday, September 1, 2021NON-FINAL ACTION WRITTEN
Thursday, August 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 10, 2021APPLICATION FILING RECEIPT MAILED
Thursday, August 12, 2021NON-FINAL ACTION WRITTEN
Friday, August 13, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 27, 2021NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, September 16, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 4, 2021REFUSAL PROCESSED BY IB
Thursday, September 2, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 16, 2021REFUSAL PROCESSED BY MPU
Tuesday, March 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 25, 2022ASSIGNED TO LIE
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, June 20, 2022LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, October 26, 2022LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, November 16, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 16, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, November 26, 2022FINAL DISPOSITION PROCESSED
Saturday, March 2, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, March 21, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 26, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, December 21, 2022FINAL DECISION TRANSACTION PROCESSED BY IB